Search - tctmd.com

Displaying 1 - 20 of 112

Sort: Relevancy | Date

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

News Daily News

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

December 21, 2017

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

December 19, 2017

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

News Daily News

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

December 15, 2017

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

Isolated Tricuspid Valve Surgery Remains Rare and Risky

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

December 13, 2017

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

News Daily News

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Yael L. Maxwell

December 12, 2017

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

News Daily News

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

December 01, 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

More Support for TMVR After Failed Mitral Bioprostheses

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

November 08, 2017

Quantitative Flow Ratio Shows Potential in Cath Lab

News Conference News TCT 2017

Quantitative Flow Ratio Shows Potential in Cath Lab

TCT Daily Staff

November 03, 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

November 02, 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

October 30, 2017

TCTMD’s Top 10 Most Popular Stories for October 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

October 29, 2017

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

October 18, 2017

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

October 16, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.